|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:GABRB3-DDX1 (FusionGDB2 ID:HG2562TG1653) |
Fusion Gene Summary for GABRB3-DDX1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: GABRB3-DDX1 | Fusion gene ID: hg2562tg1653 | Hgene | Tgene | Gene symbol | GABRB3 | DDX1 | Gene ID | 2562 | 1653 |
Gene name | gamma-aminobutyric acid type A receptor subunit beta3 | DEAD-box helicase 1 | |
Synonyms | ECA5|EIEE43 | DBP-RB|UKVH5d | |
Cytomap | ('GABRB3')('DDX1') 15q12 | 2p24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | gamma-aminobutyric acid receptor subunit beta-3GABA-alpha receptor beta-2 subunitGABAA receptor beta-3 subunitgamma-aminobutyric acid (GABA) A receptor, beta 3gamma-aminobutyric acid A receptor beta 3gamma-aminobutyric acid type A receptor beta3 subu | ATP-dependent RNA helicase DDX1DEAD (Asp-Glu-Ala-Asp) box helicase 1DEAD (Asp-Glu-Ala-Asp) box polypeptide 1DEAD box polypeptide 1DEAD box protein 1DEAD box protein retinoblastomaDEAD box-1DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 1DEAD/H-box h | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | P28472 | Q92499 | |
Ensembl transtripts involved in fusion gene | ENST00000299267, ENST00000311550, ENST00000400188, ENST00000541819, ENST00000545868, ENST00000557641, | ||
Fusion gene scores | * DoF score | 9 X 9 X 2=162 | 4 X 5 X 3=60 |
# samples | 9 | 5 | |
** MAII score | log2(9/162*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/60*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: GABRB3 [Title/Abstract] AND DDX1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | GABRB3(26790498)-DDX1(15768763), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GABRB3 | GO:0071420 | cellular response to histamine | 18281286 |
Hgene | GABRB3 | GO:1902476 | chloride transmembrane transport | 9039914 |
Hgene | GABRB3 | GO:1904862 | inhibitory synapse assembly | 25489750 |
Tgene | DDX1 | GO:0006302 | double-strand break repair | 18710941 |
Tgene | DDX1 | GO:0032508 | DNA duplex unwinding | 18710941 |
Tgene | DDX1 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 18710941 |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | BG329765 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
Top |
Fusion Gene ORF analysis for GABRB3-DDX1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000299267 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000299267 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000311550 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000311550 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000400188 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000400188 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000541819 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000541819 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000545868 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000545868 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000557641 | ENST00000233084 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
intron-3CDS | ENST00000557641 | ENST00000381341 | GABRB3 | chr15 | 26790498 | - | DDX1 | chr2 | 15768763 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for GABRB3-DDX1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for GABRB3-DDX1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:26790498/:15768763) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
GABRB3 | DDX1 |
FUNCTION: Ligand-gated chloride channel which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:18514161, PubMed:22303015, PubMed:26950270, PubMed:22243422, PubMed:24909990). Plays an important role in the formation of functional inhibitory GABAergic synapses in addition to mediating synaptic inhibition as a GABA-gated ion channel (PubMed:25489750). The gamma2 subunit is necessary but not sufficient for a rapid formation of active synaptic contacts and the synaptogenic effect of this subunit is influenced by the type of alpha and beta subunits present in the receptor pentamer (By similarity). The alpha1/beta3/gamma2 receptor exhibits synaptogenic activity (PubMed:25489750). The alpha2/beta3/gamma2 receptor shows very little or no synaptogenic activity (By similarity). Functions also as histamine receptor and mediates cellular responses to histamine (PubMed:18281286). Plays an important role in somatosensation and in the production of antinociception (By similarity). {ECO:0000250|UniProtKB:P63080, ECO:0000269|PubMed:18281286, ECO:0000269|PubMed:18514161, ECO:0000269|PubMed:22243422, ECO:0000269|PubMed:22303015, ECO:0000269|PubMed:24909990, ECO:0000269|PubMed:25489750, ECO:0000269|PubMed:26950270}. | FUNCTION: Acts as an ATP-dependent RNA helicase, able to unwind both RNA-RNA and RNA-DNA duplexes. Possesses 5' single-stranded RNA overhang nuclease activity. Possesses ATPase activity on various RNA, but not DNA polynucleotides. May play a role in RNA clearance at DNA double-strand breaks (DSBs), thereby facilitating the template-guided repair of transcriptionally active regions of the genome. Together with RELA, acts as a coactivator to enhance NF-kappa-B-mediated transcriptional activation. Acts as a positive transcriptional regulator of cyclin CCND2 expression. Binds to the cyclin CCND2 promoter region. Associates with chromatin at the NF-kappa-B promoter region via association with RELA. Binds to poly(A) RNA. May be involved in 3'-end cleavage and polyadenylation of pre-mRNAs. Component of the tRNA-splicing ligase complex required to facilitate the enzymatic turnover of catalytic subunit RTCB: together with archease (ZBTB8OS), acts by facilitating the guanylylation of RTCB, a key intermediate step in tRNA ligation (PubMed:24870230). Component of a multi-helicase-TICAM1 complex that acts as a cytoplasmic sensor of viral double-stranded RNA (dsRNA) and plays a role in the activation of a cascade of antiviral responses including the induction of proinflammatory cytokines via the adapter molecule TICAM1. Specifically binds (via helicase ATP-binding domain) on both short and long poly(I:C) dsRNA (By similarity). {ECO:0000250|UniProtKB:Q91VR5, ECO:0000269|PubMed:12183465, ECO:0000269|PubMed:15567440, ECO:0000269|PubMed:18335541, ECO:0000269|PubMed:18710941, ECO:0000269|PubMed:20573827, ECO:0000269|PubMed:24870230}.; FUNCTION: (Microbial infection) Required for HIV-1 Rev function as well as for HIV-1 and coronavirus IBV replication. Binds to the RRE sequence of HIV-1 mRNAs. {ECO:0000269|PubMed:15567440}.; FUNCTION: (Microbial infection) Required for Coronavirus IBV replication. {ECO:0000269|PubMed:20573827}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for GABRB3-DDX1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for GABRB3-DDX1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for GABRB3-DDX1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GABRB3 | P28472 | DB00898 | Ethanol | Small molecule | Approved | |
Hgene | GABRB3 | P28472 | DB06716 | Fospropofol | Potentiator | Small molecule | Approved|Illicit|Investigational |
Hgene | GABRB3 | P28472 | DB00602 | Ivermectin | Agonist | Small molecule | Approved|Investigational|Vet_approved |
Hgene | GABRB3 | P28472 | DB00818 | Propofol | Potentiator | Small molecule | Approved|Investigational|Vet_approved |
Hgene | GABRB3 | P28472 | DB00592 | Piperazine | Agonist | Small molecule | Approved|Vet_approved |
Hgene | GABRB3 | P28472 | DB00431 | Lindane | Small molecule | Approved|Withdrawn |
Top |
Related Diseases for GABRB3-DDX1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GABRB3 | C4310712 | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43 | 6 | CTD_human;UNIPROT |
Hgene | GABRB3 | C0011570 | Mental Depression | 5 | PSYGENET |
Hgene | GABRB3 | C0011581 | Depressive disorder | 5 | PSYGENET |
Hgene | GABRB3 | C0001973 | Alcoholic Intoxication, Chronic | 4 | PSYGENET |
Hgene | GABRB3 | C2677087 | EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5 | 3 | GENOMICS_ENGLAND;UNIPROT |
Hgene | GABRB3 | C0004352 | Autistic Disorder | 2 | CTD_human |
Hgene | GABRB3 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
Hgene | GABRB3 | C0014544 | Epilepsy | 2 | CTD_human |
Hgene | GABRB3 | C0036341 | Schizophrenia | 2 | PSYGENET |
Hgene | GABRB3 | C0086237 | Epilepsy, Cryptogenic | 2 | CTD_human |
Hgene | GABRB3 | C0236018 | Aura | 2 | CTD_human |
Hgene | GABRB3 | C0238111 | Lennox-Gastaut syndrome | 2 | ORPHANET |
Hgene | GABRB3 | C0751111 | Awakening Epilepsy | 2 | CTD_human |
Hgene | GABRB3 | C0001890 | Akinetic Petit Mal | 1 | CTD_human |
Hgene | GABRB3 | C0014553 | Absence Epilepsy | 1 | CTD_human |
Hgene | GABRB3 | C0021603 | Sleep Initiation and Maintenance Disorders | 1 | CTD_human |
Hgene | GABRB3 | C0033139 | Primary Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0162635 | Angelman Syndrome | 1 | CTD_human |
Hgene | GABRB3 | C0270541 | Rebound Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0349255 | Nonorganic Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Hgene | GABRB3 | C0393759 | Transient Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0541798 | Early Awakening | 1 | CTD_human |
Hgene | GABRB3 | C0751124 | Epilepsy, Absence, Atypical | 1 | CTD_human |
Hgene | GABRB3 | C0751249 | Chronic Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0751250 | Psychophysiological Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0751251 | Secondary Insomnia | 1 | CTD_human |
Hgene | GABRB3 | C0751252 | Sleep Initiation Dysfunction | 1 | CTD_human |
Hgene | GABRB3 | C0917801 | Sleeplessness | 1 | CTD_human |
Hgene | GABRB3 | C1510586 | Autism Spectrum Disorders | 1 | CTD_human |
Hgene | GABRB3 | C1535926 | Neurodevelopmental Disorders | 1 | CTD_human |
Hgene | GABRB3 | C1838604 | EPILEPSY, CHILDHOOD ABSENCE, 1 | 1 | ORPHANET |
Hgene | GABRB3 | C3711376 | Isodicentric Chromosome 15 Syndrome | 1 | CTD_human |
Hgene | GABRB3 | C4281785 | Childhood Absence Epilepsy | 1 | CTD_human |
Hgene | GABRB3 | C4317339 | Juvenile Absence Epilepsy | 1 | CTD_human |
Hgene | GABRB3 | C4552765 | Epilepsy, Minor | 1 | CTD_human |
Hgene | GABRB3 | C4553705 | Absence Seizure Disorder | 1 | CTD_human |
Tgene | C0013146 | Drug abuse | 1 | CTD_human | |
Tgene | C0013170 | Drug habituation | 1 | CTD_human | |
Tgene | C0013222 | Drug Use Disorders | 1 | CTD_human | |
Tgene | C0014173 | Endometrial Hyperplasia | 1 | CTD_human | |
Tgene | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human | |
Tgene | C0038580 | Substance Dependence | 1 | CTD_human | |
Tgene | C0038586 | Substance Use Disorders | 1 | CTD_human | |
Tgene | C0236969 | Substance-Related Disorders | 1 | CTD_human | |
Tgene | C0349578 | Complex Endometrial Hyperplasia | 1 | CTD_human | |
Tgene | C0349579 | Atypical Endometrial Hyperplasia | 1 | CTD_human | |
Tgene | C0456483 | Simple Endometrial Hyperplasia | 1 | CTD_human | |
Tgene | C0740858 | Substance abuse problem | 1 | CTD_human | |
Tgene | C1510472 | Drug Dependence | 1 | CTD_human | |
Tgene | C4316881 | Prescription Drug Abuse | 1 | CTD_human |